{
  "id": "matrixMatch_hepatitis_transmission_v2026_1771707249634_30",
  "type": "matrixMatch",
  "matrixType": "multipleChoice",
  "stem": "The nurse is reviewing the medical records of four newly admitted clients. Based on the information provided, match each hepatitis type with its primary mode of transmission and vaccine availability.",
  "itemContext": {
    "tabs": [
      {
        "id": "sbar",
        "title": "Nurses' Notes",
        "content": "07:00 SBAR for Patient A: Client reports fatigue, nausea, and jaundice for the past week. Admits to recent international travel to a region with poor sanitation. \n07:15 SBAR for Patient B: Client presents with right upper quadrant pain and dark urine. Reports a history of IV drug use and multiple sexual partners. \n07:30 SBAR for Patient C: Client is asymptomatic but has elevated liver enzymes discovered during a routine check-up. Reports a blood transfusion in the 1980s before blood screening was implemented. \n07:45 SBAR for Patient D: Client reports fatigue and flu-like symptoms. Reports attending a potluck dinner last week. Several attendees have similar symptoms. \n08:00 SBAR for Patient E: Client is a healthcare worker with a recent needle stick injury. The source patient is known to have Hepatitis B. \n"
      },
      {
        "id": "vitals",
        "title": "Vital Signs",
        "content": "Patient A: 07:00 - Temp 37.2°C, HR 88 bpm, BP 120/80 mmHg, RR 18 bpm, SpO2 98%\nPatient B: 07:15 - Temp 37.5°C, HR 92 bpm, BP 125/82 mmHg, RR 20 bpm, SpO2 97%\nPatient C: 07:30 - Temp 37.0°C, HR 78 bpm, BP 118/76 mmHg, RR 16 bpm, SpO2 99%\nPatient D: 07:45 - Temp 37.8°C, HR 96 bpm, BP 128/84 mmHg, RR 22 bpm, SpO2 96%\nPatient E: 08:00 - Temp 36.8°C, HR 72 bpm, BP 110/70 mmHg, RR 14 bpm, SpO2 99%"
      },
      {
        "id": "labs",
        "title": "Lab Results",
        "content": "Patient A: ALT 350 U/L (Ref: 7-55 U/L), AST 400 U/L (Ref: 8-48 U/L), Bilirubin 3.0 mg/dL (Ref: 0.3-1.0 mg/dL)\nPatient B: ALT 500 U/L (Ref: 7-55 U/L), AST 550 U/L (Ref: 8-48 U/L), Hepatitis B surface antigen positive\nPatient C: ALT 400 U/L (Ref: 7-55 U/L), AST 450 U/L (Ref: 8-48 U/L), Hepatitis C antibody positive\nPatient D: ALT 300 U/L (Ref: 7-55 U/L), AST 350 U/L (Ref: 8-48 U/L), IgM anti-HAV positive\nPatient E: Pending results"
      },
      {
        "id": "exam",
        "title": "Physical Exam",
        "content": "Patient A: Jaundice, scleral icterus, abdominal tenderness in the right upper quadrant.\nPatient B: Jaundice, scleral icterus, hepatomegaly, spider angiomata.\nPatient C: No acute distress, hepatomegaly.\nPatient D: Mild jaundice, fatigue, no hepatosplenomegaly.\nPatient E: No acute distress. Site of needle stick injury noted on left hand."
      },
      {
        "id": "orders",
        "title": "Care Plan",
        "content": "Patient A: Contact precautions, supportive care, monitor liver function.\nPatient B: Standard precautions, antiviral therapy, monitor liver function.\nPatient C: Standard precautions, antiviral therapy, monitor liver function.\nPatient D: Contact precautions, supportive care, monitor liver function.\nPatient E: Hepatitis B immunoglobulin (HBIG) and Hepatitis B vaccine series initiation."
      },
      {
        "id": "mar",
        "title": "MAR",
        "content": "Patient A: Ondansetron 4mg IV PRN for nausea\nPatient B: Tenofovir 300mg PO daily\nPatient C: Sofosbuvir 400mg PO daily\nPatient D: Acetaminophen 500mg PO PRN for fever\nPatient E: Hepatitis B immunoglobulin (HBIG) 0.06 mL/kg IM within 24 hours of exposure, Hepatitis B vaccine (Engerix-B) 1.0 mL IM."
      }
    ]
  },
  "rows": [
    {
      "id": "r1",
      "text": "Hepatitis A"
    },
    {
      "id": "r2",
      "text": "Hepatitis B"
    },
    {
      "id": "r3",
      "text": "Hepatitis C"
    }
  ],
  "columns": [
    {
      "id": "c1",
      "text": "Fecal-Oral Route; Vaccine Available"
    },
    {
      "id": "c2",
      "text": "Blood/Sexual Contact; Vaccine Available"
    },
    {
      "id": "c3",
      "text": "Blood Contact; No Vaccine Available"
    }
  ],
  "correctAnswers": {
    "r1": [
      "c1"
    ],
    "r2": [
      "c2"
    ],
    "r3": [
      "c3"
    ]
  },
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "analyzeCues",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 4,
    "topicTags": [
      "Hepatitis Transmission"
    ]
  },
  "rationale": {
    "correct": "Hepatitis A is primarily transmitted through the fecal-oral route, often due to contaminated food or water, and a vaccine is available for prevention. Hepatitis B is mainly transmitted through blood and sexual contact, and a vaccine is available for prevention. Hepatitis C is primarily transmitted through blood contact, such as sharing needles or blood transfusions before screening was implemented, and there is no vaccine available.",
    "incorrect": "Incorrect options present common misconceptions about hepatitis transmission and vaccine availability. Mistaking the transmission route or vaccine status can lead to inappropriate preventive measures and client education.",
    "answerBreakdown": [
      {
        "id": "r1",
        "text": "Hepatitis A",
        "rationale": "Patient D presents with symptoms and lab results consistent with acute Hepatitis A. The nurse's note indicates a recent potluck dinner, suggesting a fecal-oral route of transmission. A vaccine is available for Hepatitis A."
      },
      {
        "id": "r2",
        "text": "Hepatitis B",
        "rationale": "Patient B's history of IV drug use and multiple sexual partners, combined with a positive Hepatitis B surface antigen, indicates Hepatitis B infection. Patient E, a healthcare worker exposed to Hepatitis B, received HBIG and the Hepatitis B vaccine, reinforcing the availability of a vaccine."
      },
      {
        "id": "r3",
        "text": "Hepatitis C",
        "rationale": "Patient C's history of a blood transfusion before screening was implemented, along with elevated liver enzymes and a positive Hepatitis C antibody, indicates Hepatitis C infection. There is currently no vaccine available for Hepatitis C."
      }
    ],
    "clinicalPearls": [
      "Hepatitis A is often associated with international travel and poor sanitation.",
      "Hepatitis B can be transmitted through sexual contact and IV drug use.",
      "Hepatitis C often results from blood transfusions before screening or sharing needles.",
      "Vaccination is a key preventative measure for Hepatitis A and B, but not for Hepatitis C."
    ],
    "questionTrap": {
      "trap": "Many students confuse the transmission routes of Hepatitis B and C, particularly given their common association with blood exposure. Also, many students may assume that since Hepatitis A and B have vaccines, Hepatitis C does as well.",
      "howToOvercome": "Remember that Hepatitis A is fecal-oral, Hepatitis B has a vaccine, and Hepatitis C has no vaccine. Focus on the specifics of blood versus sexual contact for B versus C transmission."
    },
    "mnemonic": {
      "title": "ABC's of Hepatitis",
      "expansion": "A - Always Fecal-Oral; B - Blood & Body Fluids (vaccine); C - Chronic (no vaccine)."
    }
  },
  "scoring": {
    "method": "polytomous",
    "maxPoints": 3
  },
  "sentinelStatus": "healed_v2026_v9"
}